GlaxoSmithKline Urges Third Circuit to Ignore Ruling in Fosamax Case
GlaxoSmithKline PLC has asked the Third Circuit Appeals Court to ignore the ruling in a product liability case involving the drug Fosamax when deciding whether to revive a suit brought on by buyers of Wellbutrin. More...
Swiss pharma company, Basilea, receives FDA Qualified Infectious Disease Product designation for fungal drug, isavuconazole
PRESS RELEASE Basilea Pharmaceutica Ltd. announced Thursday that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive More...